Clinical trials · Atlanta, GA
Unresectable Malignant Solid Neoplasm clinical trials in Atlanta
We’re tracking 6 recruiting unresectable malignant solid neoplasm studies with a site in or near Atlanta — including Phase 1, Phase 1/Phase 2 and Phase 2 studies, each written for real people, not researchers.
Recruiting studies near Atlanta
- NCT06586957RecruitingPhase 1
Study of NKT3964 for advanced solid tumors
This trial is testing an experimental oral drug called NKT3964 for people with advanced solid tumors that have stopped responding to standard treatments. The drug works by blocking a protein called CDK2, which some cancers need to grow.
Atlanta, GeorgiaAges 18 years+ - NCT04851119RecruitingPhase 1/Phase 2
Tegavivint for kids and young adults with hard-to-treat solid tumors
This early-phase study tests tegavivint to see how well it works and how safe it is for children and young adults with solid cancers that have come back or are not responding. It may be an option if your tumor type (including certain lymphomas or desmoid tumors) matches the study’s rules.
Atlanta, GeorgiaAges 1–30 - NCT04585958RecruitingPhase 1
Combination treatment for HER2-positive cancers and resistant ovarian cancer
This trial tests a new combination of two drugs, DS-8201a and olaparib, for people with cancers that have a protein called HER2, and for those with ovarian cancer that has stopped responding to platinum chemotherapy. The goal is to see if this combination can shrink or control the cancer.
Atlanta, GeorgiaAges 18 years+ - NCT03816345RecruitingPhase 1
Nivolumab for advanced cancer with autoimmune conditions
This Phase 1 study tests nivolumab, an immunotherapy “anti-cancer accelerator,” in people with advanced cancer who also have an autoimmune disorder. It aims to see if nivolumab can be given safely and whether it may help shrink or control cancer.
Atlanta, GeorgiaAges 18 years+ - NCT05327010RecruitingPhase 2
Testing a new drug combination for advanced solid tumors
This trial is studying whether a new combination of two cancer drugs, ZEN003694 and talazoparib, can help people with advanced solid tumors that have not responded to other treatments. Talazoparib is a type of drug that targets cancer cells with certain DNA repair problems. The study is divided into groups based on specific gene mutations or previous treatment responses.
Atlanta, GeorgiaAges 18 years+ - NCT05564377RecruitingPhase 2
Find targeted cancer treatments using genetic testing
This study matches people with advanced solid tumors to targeted treatment plans based on genetic testing. It also requires tumor sample testing to help doctors choose the most promising therapy for your specific tumor changes.
Newnan, GeorgiaAges Any age
Hear when a new Unresectable Malignant Solid Neoplasm trial opens near Atlanta, GA
We’ll email you when one opens near Atlanta, GA — at most once a week, no account needed, unsubscribe anytime.
Unresectable Malignant Solid Neoplasm trials in other cities
Where these studies are running near Atlanta
Institutions with a site for the recruiting unresectable malignant solid neoplasm studies listed above.
- Emory University · 4 studies
- Cancer Treatment Centers of America at Southeastern Regional Medical Center
- Children's Healthcare of Atlanta
What taking part in a unresectable malignant solid neoplasm study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting unresectable malignant solid neoplasm studies in Georgia.
Common questions
- Are there unresectable malignant solid neoplasm clinical trials near Atlanta?
- Yes. We're currently tracking 6 recruiting unresectable malignant solid neoplasm studies with a site near Atlanta, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a unresectable malignant solid neoplasm study near Atlanta?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Atlanta to take part?
- Not necessarily. These studies have a site near Atlanta, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a unresectable malignant solid neoplasm trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New unresectable malignant solid neoplasm studies open near Atlanta regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.